Nitrosamines – Revised EMA Q&A Nitrosamines – Revised EMA Q&A An amended version of the Questions and answers for marketing authorisation holders/applicants on... Nitrosamines – Revised EMA Q&A
UK-Wide Licensing for Human Medicines Guidance Published UK-Wide Licensing for Human Medicines Guidance Published MHRA has published guidance for the UK-wide licensing of human medicines on the... UK-Wide Licensing for Human Medicines Guidance Published
Microplastics – Publication of Commission Regulation 2023/2055 in OJEU Microplastics – Publication of Commission Regulation 2023/2055 in OJEU The Commission Regulation (EU) 2023/2055 of 25 September 2023... Microplastics – Publication of Commission Regulation 2023/2055 in OJEU
MHRA Publishes Marketing Authorisations Granted 1 September to 14 September 2023 MHRA Marketing Authorisations Granted 1 September to 14 September 2023 MHRA granted three OTC licences during 1 – 14 September... MHRA Publishes Marketing Authorisations Granted 1 September to 14 September 2023
CMDh September 2023 Meeting – Report CMDh September 2023 Meeting – Report The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published... CMDh September 2023 Meeting – Report
Retained EU Law Dashboard Updated in September Retained EU Law Dashboard Updated in September A dashboard showing a list of retained EU laws (REUL) has been... Retained EU Law Dashboard Updated in September
MHRA Performance Data for Assessment of Clinical Trials and Established Medicines MHRA Performance Data for Assessment of Clinical Trials and Established Medicines MHRA has published MHRA performance metrics for clinical trials... MHRA Performance Data for Assessment of Clinical Trials and Established Medicines
MHRA Yellow Card Centre Launched in Northern Ireland MHRA Yellow Card Centre Launched in Northern Ireland A new regional centre to promote Yellow Card reporting has been... MHRA Yellow Card Centre Launched in Northern Ireland
MHRA – Marketing Authorisation Application Submission Dates for 150-days Assessment Procedure MHRA – Marketing Authorisation Application Submission Dates for 150-days Assessment Procedure MHRA has updated the Commission on Human Medicines (CHM)... MHRA – Marketing Authorisation Application Submission Dates for 150-days Assessment Procedure
EMA ISG Meeting 26 June 2023 – EMA Highlights Published EMA ISG Meeting 26 June 2023 – EMA Highlights Published The European Medicines Agency (EMA) has published the highlights from... EMA ISG Meeting 26 June 2023 – EMA Highlights Published
MHRA Marketing Authorisations Granted 15 August to 31 August 2023 MHRA Marketing Authorisations Granted 15 August to 31 August 2023 MHRA granted two OTC licences during 15 – 31 August... MHRA Marketing Authorisations Granted 15 August to 31 August 2023
DHSC Consultation – Disclosure of Industry Payments to the Healthcare Sector DHSC Consultation – Disclosure of Industry Payments to the Healthcare Sector The Department of Health and Social Care (DHSC) has... DHSC Consultation – Disclosure of Industry Payments to the Healthcare Sector
